ArticleInvestigational new drugs2022

Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies.

Yu Sunakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.